FDA provides breakthrough device designation to MeMed BV Flex
The U.S. Food and Drug Administration has granted Breakthrough Device designation to MeMed BV Flex, a blood test that differentiates between bacterial and viral infections.
Medical Xpress
via Medical Xpress
Updated 3h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
How Will Martian Gravity Affect Skeletal Muscle?
Next
TSA wait times are unpredictable amid government shutdown : NPR
Related Articles
HealthJapan hints at deploying self-defense forces for minesweeping in Hormuz
Unknown-38m ago-1 sources
HealthNairobi conference to chart solutions for Uganda’s maternal health gaps
Prossy Nandudu-1h ago-1 sources
HealthThe growing concern: Watch out for early signs of emotional overload in children
Dr Preetha Reddy-1h ago-1 sources